Back

Multi-omics interrogation of energy metabolism reveals novel causal targets in pulmonary arterial hypertension

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pathophysiology and mechanisms Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Shiqiang Hou

Zhongshan Hospital Fudan University, Shanghai (China)

7 More presentations in this session

Presentation thumbnail
Plasma apelin levels in pulmonary arterial hypertension: a potential early diagnostic biomarker?
Doctor C. Tunca (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Exploratory study on the inhibitory effect of dihydrotanshinone on RNA-binding protein (HuR) in the treatment of pulmonary heart disease with right ventricular fibrosis
Professor X. Yu (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular and metabolic comorbidities shape endothelial dysfunction in pulmonary arterial hypertension and may influence treatment: insights from a multicenter translational network
Associate Professor R. Madonna (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
CCR6⁺ T cells as potential drivers of inflammation in chronic thromboembolic pulmonary hypertension
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Peripheral T-cell remodeling in long-standing PAH: CD4+ reduction and CCR6 enrichment
Miss C. Ferreira (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary hypertension: pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling the diagnostic significance and immune infiltration impact of disulfidptosis-associated genes in pulmonary hypertension
30 August 2025
thumbnail
Congress Presentation
Bidirectional mendelian randomzation study of TET2-clonal haematopoiesis of indeterminate potential-mutations with hs-CRP in patients with STEMI
30 August 2026
thumbnail
Congress Presentation
Imbalanced ω-6/ω-3 polyunsaturated fatty acid metabolism promotes HFpEF progression via the ANGPTL4/LPL axis-mediated lipotoxicity
28 August 2026
thumbnail
Congress Presentation
ROBO4 triggers pulmonary arterial hypertension through promoting the progressive reduction of pulmonary micro-vessels and the remodeling of distal pulmonary arterioles
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources